
### [NCIT:C7420](http://purl.obolibrary.org/obo/NCIT_C7420)
**Label:** Malignant Rectosigmoid Neoplasm

**Subclasses:** [NCIT:C8636](http://purl.obolibrary.org/obo/NCIT_C8636) (Stage IV Rectosigmoid Cancer AJCC v6), [NCIT:C5015](http://purl.obolibrary.org/obo/NCIT_C5015) (Stage II Rectosigmoid Cancer AJCC v6), [NCIT:C5016](http://purl.obolibrary.org/obo/NCIT_C5016) (Stage I Rectosigmoid Cancer AJCC v6 and v7), [NCIT:C8634](http://purl.obolibrary.org/obo/NCIT_C8634) (Recurrent Rectosigmoid Carcinoma), [NCIT:C5017](http://purl.obolibrary.org/obo/NCIT_C5017) (Stage 0 Rectosigmoid Cancer AJCC v6 and v7), [NCIT:C43592](http://purl.obolibrary.org/obo/NCIT_C43592) (Rectosigmoid Mucinous Adenocarcinoma), [NCIT:C8635](http://purl.obolibrary.org/obo/NCIT_C8635) (Stage III Rectosigmoid Cancer AJCC v6), [NCIT:C43593](http://purl.obolibrary.org/obo/NCIT_C43593) (Rectosigmoid Signet Ring Cell Carcinoma), [NCIT:C7421](http://purl.obolibrary.org/obo/NCIT_C7421) (Rectosigmoid Carcinoma), [NCIT:C43584](http://purl.obolibrary.org/obo/NCIT_C43584) (Rectosigmoid Adenocarcinoma), [NCIT:C91226](http://purl.obolibrary.org/obo/NCIT_C91226) (Rectosigmoid Cancer by AJCC v7 Stage), [NCIT:C89992](http://purl.obolibrary.org/obo/NCIT_C89992) (Stage II Rectosigmoid Cancer AJCC v7), [NCIT:C89997](http://purl.obolibrary.org/obo/NCIT_C89997) (Stage III Rectosigmoid Cancer AJCC v7), [NCIT:C90509](http://purl.obolibrary.org/obo/NCIT_C90509) (Rectosigmoid Cancer by AJCC v6 Stage), [NCIT:C90019](http://purl.obolibrary.org/obo/NCIT_C90019) (Stage IV Rectosigmoid Cancer AJCC v7), 

**Class expressions from DL-Learner:**

- [UBERON:0036214](http://purl.obolibrary.org/obo/UBERON_0036214) (rectosigmoid junction) 62.50%
- [UBERON:0012652](http://purl.obolibrary.org/obo/UBERON_0012652) (colorectum) 62.50%
- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 62.50%
- Thing 51.60%
- [UBERON:0007651](http://purl.obolibrary.org/obo/UBERON_0007651) (anatomical junction) 31.40%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 27.36%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 27.29%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 27.15%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 27.14%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 27.01%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 27.01%
- [UBERON:0000064](http://purl.obolibrary.org/obo/UBERON_0000064) (organ part) 15.83%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 15.74%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 14.98%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 14.87%


